Acute cellular transplant rejection following laparoscopic adjustable gastric banding in a morbidly obese patient post heart transplantation

Journal of Cardiovascular Medicine

Volumn 11, Issue 9, 2010, Pages 695-699

  Unes Kunju, Shebna ^a   Naim, H Joseph ^a   Czer, Lawrence ^a   Simsir, Sinan ^a   Schwarz, Ernst R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

bariatric surgery; heart transplantation; obesity

Indexed keywords

DIURETIC AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; AFRICAN AMERICAN; ARTICLE; CARDIAC GRAFT REJECTION; CASE REPORT; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIET THERAPY; DIURETIC THERAPY; DRUG ABSORPTION; DRUG DOSE INCREASE; DYSPNEA; EDEMA; EXERCISE; EXERCISE TOLERANCE; GASTRIC BANDING; GASTROINTESTINAL MOTILITY DISORDER; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTENSION; HYPOVENTILATION; IMMUNOSUPPRESSIVE TREATMENT; INFERIOR CAVA VEIN; LAPAROSCOPIC SURGERY; LOW BACK PAIN; LUNG EMBOLISM; MALE; MORBID OBESITY; ORTHOTOPIC TRANSPLANTATION; SLEEP APNEA SYNDROME; STEROID THERAPY; STOMACH EMPTYING; THORAX PAIN; TRICUSPID VALVE REGURGITATION; VENA CAVA FILTER; WEIGHT REDUCTION;

ACUTE DISEASE; ADULT; BARIATRIC SURGERY; BIOPSY; CARDIOMYOPATHY, DILATED; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; MALE; OBESITY, MORBID;

EID: 77955178542     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328332e6f1     Document Type: Article

References (39)

1. Drewnowski A, Popkin BM. The nutrition transition: new trends in the global diet. Nutr Rev 1997; 55:31-43.
2. Keil U, Kuulasmaa K. WHO MONICA Project: risk factors. Int J Epidemiol 1989; 18:S46-55.
3. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:1-253.
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J Am Med Assoc 2003; 289:76-79.
5. Grady KL, Naftel D, Pamboukian SV, Frazier OH, Hauptman P, Herre J, et al. Postoperative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multiinstitutional study of postoperative weight change. J Heart Lung Transplant 2005; 24:1424-1430.
6. Gordon T, Kannel WB. Obesity and cardiovascular diseases: the Framingham study. Clin Endocrinol Metab 1976; 5:367-375.
7. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord 2002; 26:1046-1053.
8. Baum CL, Thielke K, Westin E, Kogan E, Cicalese L, Benedetti E. Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition 2002; 18:139-146.
9. Zarraga IG, Schwarz ER. Impact of dietary patterns and interventions on cardiovascular health. Circulation 2006; 114:961-973.
10. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998; 158:1855-1867.
11. National Institutes of Health Consensus Development Conference Draft Statement on Gastrointestinal Surgery for Severe Obesity. Obes Surg 1991; 1:257-265.
12. Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 2005; 15:641-647.
13. Weiss H, Nehoda H, Labeck B, Oberwalder M, Konigsrainer A, Margreiter R. Organ transplantation and obesity: evaluation, risks and benefits of therapeutic strategies. Obes Surg 2000; 10:465-469.
14. Newcombe V, Blanch A, Slater GH, Szold A, Fielding GA. Laparoscopic adjustable gastric banding prior to renal transplantation. Obes Surg 2005; 15:567-570. (Pubitemid 40605085)
15. Ablassmaier B, Klaua S, Jacobi CA, Muller JM. Laparoscopic gastric banding after heart transplantation. Obes Surg 2002; 12:412-415.
16. Stewart S, Winters GL, FishbeinMC, Tazelaar HD, Kobashigawa J, Abrams J, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720.
17. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Prog Cardiovasc Dis 1999; 42:39-58.
18. Howard BV, Ruotolo G, Robbins DC.Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32:855-867.
19. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
20. Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke 2004; 35:2764-2769.
21. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160:898-904.
22. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28:629-636.
23. Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A:344-350.
24. Jubber AS. Respiratory complications of obesity. Int J Clin Pract 2004; 58:573-580.
25. Rex IH, Hull D, Trowbridge PE. Gastroplasty for morbid obesity after cardiac and renal transplantation. Obes Surg 1991; 1:439-442.
26. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7:158-165.
27. Hricik DE. Posttransplant hyperlipidemia: the treatment dilemma. Am J Kidney Dis 1994; 23:766-771.
28. Cattran DC, Steiner G, Wilson DR, Fenton SA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979; 91:554-559.
29. Jindal RM, Sidner RA, Hughes D, Pescovitz MD, Leapman SB, Milgrom ML, et al. Metabolic problems in recipients of liver transplants. Clin Transplant 1996; 10:213-217. (Pubitemid 26091836)
30. Johnson CP, Gallagher-Lepak S, Zhu YR, Porth C, Kelber S, Roza AM, Adams MB. Factors influencing weight gain after renal transplantation. Transplantation 1993; 56:822-827.
31. Clunk JM, Lin CY, Curtis JJ. Variables affecting weight gain in renal transplant recipients. Am J Kidney Dis 2001; 38:349-353.
32. Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol 1977; 43:1001-1006.
33. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. J Am Med Assoc 2004; 292:1724-1737.
34. Nagele H, Petersen B, Bonacker U, Rodiger W. Effect of orlistat on blood cyclosporin concentration in an obese heart transplant patient. Eur J Clin Pharmacol 1999; 55:667-669.
35. Lopez Deogracias M, Dominguez-Diez A, Palomar-Fontanet R, Gonzalez- Noriega M, Rodrigo E, Fernandez-Fresnedo G, et al. Biliopancreatic diversion in a renal transplant patient. Obes Surg 2007; 17:553-555.
36. Macgregor AM, Boggs L. Drug distribution in obesity and following bariatric surgery: a literature review. Obes Surg 1996; 6:17-27.
37. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006; 63:1852-1857.
38. Marterre WF, Hariharan S, First MR, Alexander JW. Gastric bypass in morbidly obese kidney transplant recipients. Clin Transplant 1996; 10:414-419.
39. Rogers CC, Alloway RR, Alexander JW, Cardi M, Trofe J, Vinks AA. Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study. Clin Transplant 2008; 22:281-291.